These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26219935)

  • 81. Inflammatory bowel disease presenting as travellers' diarrhoea.
    Schumacher G; Kollberg B; Ljungh A
    Lancet; 1993 Jan; 341(8839):241-2. PubMed ID: 8093522
    [No Abstract]   [Full Text] [Related]  

  • 82. Challenges in the diagnosis and management of inflammatory bowel disease in resource-limited settings in Asia.
    Banerjee R; Pal P; Mak JWY; Ng SC
    Lancet Gastroenterol Hepatol; 2020 Dec; 5(12):1076-1088. PubMed ID: 33181087
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Reporting ileocolonoscopy in inflammatory bowel disease.
    Marshall JK
    Can J Gastroenterol; 2006 Jun; 20(6):399-400. PubMed ID: 16779456
    [No Abstract]   [Full Text] [Related]  

  • 84. Inadequate follow-up time bias: the appearance of genetic anticipation and temporal trends in IBD.
    Picco MF
    Am J Gastroenterol; 2002 Mar; 97(3):517-8. PubMed ID: 11922539
    [No Abstract]   [Full Text] [Related]  

  • 85. Lessons from geographic mapping of IBD in France.
    Green C; Bernstein CN
    Inflamm Bowel Dis; 2010 May; 16(5):804-6. PubMed ID: 19753639
    [No Abstract]   [Full Text] [Related]  

  • 86. Prolidase Deficiency in Very Early Onset Inflammatory Bowel Disease (VEO-IBD).
    Madhusudan M; Sankaranarayanan S; Ramamoorthy R; Munirathnam D; Sivasankaran M
    Indian J Pediatr; 2021 May; 88(5):503. PubMed ID: 33420638
    [No Abstract]   [Full Text] [Related]  

  • 87. Preclinical disease and preventive strategies in IBD: perspectives, challenges and opportunities.
    Torres J; Burisch J; Riddle M; Dubinsky M; Colombel JF
    Gut; 2016 Jul; 65(7):1061-9. PubMed ID: 27196600
    [No Abstract]   [Full Text] [Related]  

  • 88. Inflammatory bowel disease: review and future view.
    Maher MM
    Front Biosci (Elite Ed); 2012 Jan; 4(5):1638-47. PubMed ID: 22201980
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Histoseminar on inflammatory bowel diseases (IBD). Introduction - pathologist's role in diagnosis and surveillance in 2017].
    Fléjou JF
    Ann Pathol; 2017 Aug; 37(4):279-280. PubMed ID: 28739215
    [No Abstract]   [Full Text] [Related]  

  • 90. Is There a New Classification of Inflammatory Bowel Disease (IBD)-Adult-Onset Mixed IBD.
    Ye L; Jiang Z; Liu J; Zhou W; Cao Q
    Inflamm Bowel Dis; 2018 Apr; 24(5):e19-e20. PubMed ID: 29688468
    [No Abstract]   [Full Text] [Related]  

  • 91. A Pattern-based Approach and Multidisciplinary Discussion Are Fundamental for Diagnosis in Very Early Onset Inflammatory Bowel Disease (VEO-IBD).
    Grillo F; Mastracci L; Parente P
    Adv Anat Pathol; 2022 Jul; 29(4):259-260. PubMed ID: 35389893
    [No Abstract]   [Full Text] [Related]  

  • 92. Reply to: A Pattern-based Approach and Multidisciplinary Discussion Are Fundamental for Diagnosis in Very Early Onset Inflammatory Bowel Disease (VEO-IBD).
    Wilkins BJ; Kelsen JR; Conrad MA
    Adv Anat Pathol; 2022 Jul; 29(4):260-261. PubMed ID: 35389895
    [No Abstract]   [Full Text] [Related]  

  • 93. Concise Commentary: Is Splitting the Difference? Identifying Risk Factors Associated with Suboptimal Bowel Preparation for Colonoscopy Among IBD Patients.
    Sultan K; Trindade AJ
    Dig Dis Sci; 2022 Oct; 67(10):4602-4603. PubMed ID: 35579796
    [No Abstract]   [Full Text] [Related]  

  • 94. Editorial: elderly onset inflammatory bowel disease - clues from the largest population-based cohort study.
    Estevinho MM; Magro F
    Aliment Pharmacol Ther; 2023 Jul; 58(1):116-117. PubMed ID: 37307541
    [No Abstract]   [Full Text] [Related]  

  • 95. Letter: Elderly onset inflammatory bowel disease-Treat to target approach is still warranted.
    Andrew B; Srinivasan A; Zhou A; Vasudevan A
    Aliment Pharmacol Ther; 2023 Sep; 58(5):556-557. PubMed ID: 37559520
    [No Abstract]   [Full Text] [Related]  

  • 96. Epidemiology and clinical course of late onset inflammatory bowel disease.
    Viola A; Fiorino G; Costantino G; Fries W
    Minerva Gastroenterol (Torino); 2024 Mar; 70(1):52-58. PubMed ID: 34057332
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Frailty, Thy Diagnosis Is Uncertain: Impact on IBD Readmission and Mortality.
    Hong SJ; Katz S
    Dig Dis Sci; 2021 Dec; 66(12):4070-4071. PubMed ID: 33748912
    [No Abstract]   [Full Text] [Related]  

  • 98. Preclinical IBD: One more piece of the puzzle.
    Agrawal M; Torres J
    United European Gastroenterol J; 2023 Feb; 11(1):5-6. PubMed ID: 36650633
    [No Abstract]   [Full Text] [Related]  

  • 99. Is the incidence of paediatric inflammatory bowel disease still increasing?
    Ashton JJ; Cullen M; Afzal NA; Coelho T; Batra A; Beattie RM
    Arch Dis Child; 2018 Nov; 103(11):1093-1094. PubMed ID: 29519945
    [No Abstract]   [Full Text] [Related]  

  • 100. Finding a Needle in the Haystack? Defining the Role of Random Biopsies in IBD Dysplasia Surveillance.
    Ahmed W; Lukin DJ
    Inflamm Bowel Dis; 2021 May; 27(6):787-790. PubMed ID: 32812050
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.